Biohaven (BHVN) Other financing activities (2021 - 2026)

Biohaven has reported Other financing activities for 5 years, with the latest figure at -$1.8 million in Q4 2025.

• Quarterly Other financing activities rose 72.14% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$563000.0 (down 140.01% YoY) and the FY2025 annual result came in at -$194000.0, down 108.59% from the prior year.
• Other financing activities declined to -$1.8 million in Q4 2025 per BHVN's latest filing, from $1.6 million in the prior quarter.
• Over five years, Other financing activities peaked at $86.8 million in Q2 2022 and troughed at -$252.4 million in Q4 2021.
• A 5-year average of -$21.0 million and a median of $794000.0 in 2023 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 456.48% in 2024, down 234.7% in 2024.
• Over 5 years, Other financing activities stood at -$252.4 million in 2021, then grew by 6.11% to -$237.0 million in 2022, then jumped by 101.98% to $4.7 million in 2023, then tumbled by 234.7% to -$6.3 million in 2024, then surged by 72.14% to -$1.8 million in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered -$1.8 million, $1.6 million, and -$369000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.